Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 6/20 | 0.45 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.41 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.35 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.33 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.33 |
| ▸ | ITGAL | P20701 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.32 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.32 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24530274 | 0.91 | BAZ2B (0.42) | BAZ2BHTTHPGDNCOA1NCOA3 | |
| SCHEMBL880222 | 0.76 | BAZ2B (0.47) | BAZ2BHTTHPGDNCOA1NCOA3 | |
| SCHEMBL31321782 | 0.75 | BAZ2B (0.44) | BAZ2BHTTHPGDNCOA1NCOA3 | |
| SCHEMBL31321785 | 0.75 | BAZ2B (0.44) | BAZ2BHTTHPGDNCOA1NCOA3 | |
| SCHEMBL17525893 | 0.75 | BAZ2B (0.41) | BAZ2BHTTHPGDNCOA1NCOA3 | |
| SCHEMBL4141774 | 0.74 | BAZ2B (0.46) | BAZ2BHTTHPGDNCOA1NCOA3 | |
| SCHEMBL16081660 | 0.74 | BAZ2B (0.40) | BAZ2BHTTHPGDNCOA1NCOA3 | |
| SCHEMBL17525892 | 0.74 | BAZ2B (0.40) | BAZ2BHTTHPGDNCOA1NCOA3 | |
| SCHEMBL10819299 | 0.74 | BAZ2B (0.40) | BAZ2BHTTHPGDNCOA1NCOA3 | |
| SCHEMBL13377540 | 0.74 | BAZ2B (0.40) | BAZ2BHTTHPGDNCOA1NCOA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4611013-A1 | SOLID ELECTROLYTIC CAPACITOR AND MANUFACTURING METHOD | Nippon Chemi-Con Corporation (JP) | 2025-09-03 | — | — | EP | disclosed |
| US-20250174409-A1 | SOLID ELECTROLYTE CAPACITOR AND METHOD FOR MANUFACTURING SAME | CARLIT CO., LTD. (JP) | 2025-05-29 | — | — | US | disclosed |
| WO-2025052748-A1 | METHOD FOR PRODUCING SOLID ELECTROLYTIC CAPACITOR | 株式会社カーリット | 2025-03-13 | — | — | WO | disclosed |
| CN-114730665-B | Electrolyte for electrolytic capacitor and electrolytic capacitor | 富山药品工业株式会社 | 2024-12-20 | — | — | CN | disclosed |
| CN-118843914-A | Solid electrolytic capacitor and method for manufacturing the same | 佳里多股份公司 | 2024-10-25 | — | — | CN | disclosed |
| US-11778893-B2 | Indaceno derivatives as organic semiconductors | CLAP CO., LTD. (KR) | 2023-10-03 | — | — | US | disclosed |
| US-11778893-B2 | Indaceno derivatives as organic semiconductors | CLAP CO., LTD. (KR) | 2023-10-03 | — | — | US | disclosed |
| US-11771738-B2 | Endoparasitic depsipeptides | ZOETIS SERVICES LLC (US) | 2023-10-03 | — | — | US | disclosed |
| US-11771738-B2 | Endoparasitic depsipeptides | ZOETIS SERVICES LLC (US) | 2023-10-03 | — | — | US | disclosed |
| WO-2023171344-A1 | SOLID ELECTROLYTE CAPACITOR AND METHOD FOR MANUFACTURING SAME | カーリットホールディングス株式会社 | 2023-09-14 | — | — | WO | disclosed |
| WO-2009026377-A1 | METAL-CONTAINING POLYMERS AND USES THEREOF | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2009-02-26 | — | — | WO | disclosed |
| US-7361728-B1 | Electrically conducting materials from branched end-capping intermediates | TDA RESEARCH, INC. (US) | 2008-04-22 | — | — | US | disclosed |
| US-7358326-B2 | Multifunctional 3,4-alkylenedioxythiophene derivatives and electrically conductive polymers containing them | H.C. STARCK GMBH (DE) | 2008-04-15 | — | — | US | disclosed |
| US-7332858-B2 | Light emitting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-02-19 | — | — | US | disclosed |
| US-7332858-B2 | Light emitting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-02-19 | — | — | US | disclosed |
| US-7321037-B2 | Photosensitizer dye | NATIONAL CENTRAL UNIVERSITY (TW) | 2008-01-22 | — | — | US | disclosed |
| US-20070265443-A1 | PHOTOSENSITIZER DYE | NATIONAL CENTRAL UNIVERSITY (TW) | 2007-11-15 | — | — | US | disclosed |
| US-20070221884-A1 | Liminescent Silicon Oxide Flakes | CIBA SPECIALTY CHEMICALS CORP. | 2007-09-27 | — | — | US | disclosed |
| US-20070089248-A1 | Cosmetic formulations comprising diketo-pyrrolo pyrrole pigments | WALLQUIST OLOF | 2007-04-26 | — | — | US | disclosed |
| US-20070089248-A1 | Cosmetic formulations comprising diketo-pyrrolo pyrrole pigments | WALLQUIST OLOF | 2007-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070265443-A1 | PHOTOSENSITIZER DYE | CRY2, CRY1, TYR | BAZ2B 1316/4885HTT 1667/4885HPGD 3879/4885 |
| US-11771738-B2 | Endoparasitic depsipeptides | VIP, PREP, VIPR1 | BAZ2B 3200/4885HTT 3137/4885HPGD 1639/4885 |
| US-20070089248-A1 | Cosmetic formulations comprising diketo-pyrrolo pyrrole pigments | TYR, LAGE3, KRT18 | BAZ2B 436/4885HTT 936/4885HPGD 1965/4885 |
| US-11778893-B2 | Indaceno derivatives as organic semiconductors | IPO11, CYP1B1, IDO1 | BAZ2B 3302/4885HTT 1343/4885HPGD 2107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.